NCT04152369

Brief Summary

The aim of the study is to determine optimal safe duration of antibiotic prophylaxis in patients undergoing endourological procedures and ESWL, presenting with asymptomatic bacteriuria caused by multi-drug resistant bacterial strains. In this study we compare safety and efficacy of a one-day vs. three-day AMP (Antimicrobial Prophylaxis) in the above mentioned group of patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2016

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

October 29, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 5, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
Last Updated

February 20, 2020

Status Verified

February 1, 2020

Enrollment Period

4 years

First QC Date

October 29, 2019

Last Update Submit

February 19, 2020

Conditions

Keywords

ESBL+Antimicrobial prophylaxis

Outcome Measures

Primary Outcomes (4)

  • Safety and efficacy of perioperative antibiotic prophylaxis in patients with Enterobacteriacae ESBL+ urinary tract colonization undergoing endourological procedures and ESWL (Extracorporeal Shock Wave Lithotripsy).

    To determine if a 1-day perioperative antibiotic prophylaxis is as safe and effective as 3-day perioperative antibiotic prophylaxis in patients with Enterobacteriacae ESBL+ urinary tract colonization undergoing endourological procedures. This conclusion will be based on measurements of CRP \[mg/dl\] as follows: one day prior to procedure, one day post and 7 days after the procedure. The data will be statistically analyzed.

    7 days

  • Safety and efficacy of perioperative antibiotic prophylaxis in patients with Enterobacteriacae ESBL+ urinary tract colonization undergoing endourological procedures and ESWL (Extracorporeal Shock Wave Lithotripsy).

    To determine if a 1-day perioperative antibiotic prophylaxis is as safe and effective as 3-day perioperative antibiotic prophylaxis in patients with Enterobacteriacae ESBL+ urinary tract colonization undergoing endourological procedures. This conclusion will be based on measurements of WBC level \[x 10\^9/l\] as follows: one day prior to procedure, one day post and 7 days after the procedure. The data will be statistically analyzed.

    7 days

  • Safety and efficacy of perioperative antibiotic prophylaxis in patients with Enterobacteriacae ESBL+ urinary tract colonization undergoing endourological procedures and ESWL (Extracorporeal Shock Wave Lithotripsy).

    To determine if a 1-day perioperative antibiotic prophylaxis is as safe and effective as 3-day perioperative antibiotic prophylaxis in patients with Enterobacteriacae ESBL+ urinary tract colonization undergoing endourological procedures. This conclusion will be based on measurements of levels of prokalcytonin \[ng/ml\] as follows: one day prior to procedure, one day post and 7 days after the procedure. The data will be statistically analyzed.

    7 days

  • Safety and efficacy of perioperative antibiotic prophylaxis in patients with Enterobacteriacae ESBL+ urinary tract colonization undergoing endourological procedures and ESWL (Extracorporeal Shock Wave Lithotripsy).

    To determine if a 1-day perioperative antibiotic prophylaxis is as safe and effective as 3-day perioperative antibiotic prophylaxis in patients with Enterobacteriacae ESBL+ urinary tract colonization undergoing endourological procedures. This conclusion will be based on measurements of body temperature \[Celsius\] as follows: one day prior to procedure, one day post and 7 days after the procedure. The data will be statistically analyzed.

    7 days

Study Arms (2)

24 hour prophylaxis

ACTIVE COMPARATOR

In this group patients received a AMP for the day of the procedure

Procedure: Anti-microbial prophylaxis for an endourological procedure or ESWL

72 hour prophylaxis

ACTIVE COMPARATOR

In this group patients received a AMP one day prior, on the day of the procedure and the following day.

Procedure: Anti-microbial prophylaxis for an endourological procedure or ESWL

Interventions

anti-microbial prophylaxis according to urine culture results

24 hour prophylaxis72 hour prophylaxis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ESBL+ asymptomatic bacteriuria
  • assigned for endourological procedure
  • normal CRP, PCT and WBC
  • patient's consent

You may not qualify if:

  • urinary tract infection
  • raised levels of CRP, PCT, WBC
  • fever
  • non ESBL+ bacteriuria
  • inability to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Military Institue of Medicine

Warsaw, Masovian Voivodeship, 04-141, Poland

RECRUITING

MeSH Terms

Interventions

Lithotripsy

Intervention Hierarchy (Ancestors)

TherapeuticsUltrasonic Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Marcin A Radko, MD

    Military Institute of Medicine

    PRINCIPAL INVESTIGATOR
  • Henryk Zieliński, Professor

    Military Institute of Medicine

    STUDY CHAIR

Central Study Contacts

Marcin A Radko, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 29, 2019

First Posted

November 5, 2019

Study Start

July 15, 2016

Primary Completion

June 30, 2020

Study Completion

June 30, 2020

Last Updated

February 20, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations